e-learning
resources
Munich 2006
Monday 04.09.2006
Various parenchymal lung diseases and pulmonary hypertension
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Absolute 6-minute walk distance introduces a selection bias in pulmonary hypertension studies
S. A. van Wolferen, A. Boonstra, P. E. Postmus, A. Vonk-Noordegraaf (Amsterdam, Netherlands)
Source:
Annual Congress 2006 - Various parenchymal lung diseases and pulmonary hypertension
Session:
Various parenchymal lung diseases and pulmonary hypertension
Session type:
Poster Discussion
Number:
2278
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. A. van Wolferen, A. Boonstra, P. E. Postmus, A. Vonk-Noordegraaf (Amsterdam, Netherlands). Absolute 6-minute walk distance introduces a selection bias in pulmonary hypertension studies. Eur Respir J 2006; 28: Suppl. 50, 2278
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The definition of pulmonary hypertension: history, practical implications and current controversies
Should we screen for hereditary pulmonary hypertension?
Patient with ankylosing spondylitis and pulmonary hypertension
Related content which might interest you:
The need to move from 6-minute walk distance to outcome trials in pulmonary arterial hypertension
Source: Eur Respir Rev 2013; 22: 487-494
Year: 2013
The role of per cent predicted 6-min walk distance in pulmonary arterial hypertension
Source: Eur Respir J 2010; 36: 1294-1301
Year: 2010
Validation and comparison of reference equations for the 6-min walk distance test
Source: Eur Respir J 2008; 31: 571-578
Year: 2008
Interpretation of treatment changes in 6-minute walk distance in patients with COPD
Source: Eur Respir J 2008; 32: 637-643
Year: 2008
The prognostic value of percent predicted six-minute walk distance in pulmonary arterial hypertension
Source: Annual Congress 2009 - Clinical management of pulmonary arterial hypertension
Year: 2009
The 6-min walk distance: change over time and value as a predictor of survival in severe COPD
Source: Eur Respir J 2004; 23: 28-33
Year: 2004
The clinical relevance of heart rate increase in the interpretation of six-minute walk test in pulmonary hypertension
Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology
Year: 2012
Predictors for longitudinal change in 6-minute walk distance in COPD patients
Source: Annual Congress 2012 - Outcomes and assessment methods in physiotherapy and rehabilitation
Year: 2012
6-minute walk distance as a predictor of outcome in idiopathic pulmonary fibrosis
Source: Eur Respir J 2014; 43: 1822-1823
Year: 2014
6-minute walk distance as a predictor of outcome in idiopathic pulmonary fibrosis
Source: Eur Respir J 2014; 43: 1823-1824
Year: 2014
Role of exercise cardiac index to predict NYHA functional class, 6-minute walk test distance and survival in idiopathic, heritable and anorexigen-associated pulmonary arterial hypertension
Source: Annual Congress 2011 - Physiology of human pulmonary hypertension
Year: 2011
Evaluating impairment in exercise capacity in COPD patients with the six-minute walk distance test: a comparative study
Source: Eur Respir J 2006; 28: Suppl. 50, 767s
Year: 2006
Validation of the current equations to estimate peak work load based on 6-min walk distance and general demographics in COPD patients entering pulmonary rehabilitation
Source: Annual Congress 2011 - Skeletal muscle weakness in COPD: physical (in)activity and biological markers
Year: 2011
Estimation of peak work load based on 6-min walk distance and general demographics in patients with COPD: A new regression equation
Source: Annual Congress 2011 - Exercise tests and emerging outcomes: defining the impact of pulmonary rehabilitation
Year: 2011
Using the six-minute walk test to assess exercise capacity in people with pulmonary hypertension
Source: Annual Congress 2012 - Assessment of physical activity, exercise, muscle function and clinical characteristics as outcomes in physiotherapy and rehabilitation
Year: 2012
Percent predicted six-minute walk distance and prognosis in PAH
Source: Annual Congress 2010 - Pulmonary circulation: clinical aspects
Year: 2010
6-minute walk testing in COPD: is it reproducible?
Source: Eur Respir J 2011; 38: 244-245
Year: 2011
The 6-min walking distance: long-term follow up in patients with COPD
Source: Eur Respir J 2007; 29: 535-540
Year: 2007
Is 6-minute walk distance (6MWD) associated with long-term outcomes in pulmonary arterial hypertension (PAH)? Results from SERAPHIN
Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Year: 2013
The 6-minute walk test adjusted for peak heart rate correlates with stroke volume index in pulmonary arterial hypertension
Source: Annual Congress 2004 - Pulmonary hypertension
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept